249 related articles for article (PubMed ID: 33483373)
1. The Irradiated Brain Microenvironment Supports Glioma Stemness and Survival via Astrocyte-Derived Transglutaminase 2.
Berg TJ; Marques C; Pantazopoulou V; Johansson E; von Stedingk K; Lindgren D; Jeannot P; Pietras EJ; Bergström T; Swartling FJ; Governa V; Bengzon J; Belting M; Axelson H; Squatrito M; Pietras A
Cancer Res; 2021 Apr; 81(8):2101-2115. PubMed ID: 33483373
[TBL] [Abstract][Full Text] [Related]
2. Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling.
Yin J; Oh YT; Kim JY; Kim SS; Choi E; Kim TH; Hong JH; Chang N; Cho HJ; Sa JK; Kim JC; Kwon HJ; Park S; Lin W; Nakano I; Gwak HS; Yoo H; Lee SH; Lee J; Kim JH; Kim SY; Nam DH; Park MJ; Park JB
Cancer Res; 2017 Sep; 77(18):4973-4984. PubMed ID: 28754668
[TBL] [Abstract][Full Text] [Related]
3. TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells.
Fu J; Yang QY; Sai K; Chen FR; Pang JC; Ng HK; Kwan AL; Chen ZP
Neuro Oncol; 2013 Oct; 15(10):1353-65. PubMed ID: 23877317
[TBL] [Abstract][Full Text] [Related]
4. Sustained radiosensitization of hypoxic glioma cells after oxygen pretreatment in an animal model of glioblastoma and in vitro models of tumor hypoxia.
Clarke RH; Moosa S; Anzivino M; Wang Y; Floyd DH; Purow BW; Lee KS
PLoS One; 2014; 9(10):e111199. PubMed ID: 25350400
[TBL] [Abstract][Full Text] [Related]
5. Elimination of Radiation-Induced Senescence in the Brain Tumor Microenvironment Attenuates Glioblastoma Recurrence.
Fletcher-Sananikone E; Kanji S; Tomimatsu N; Di Cristofaro LFM; Kollipara RK; Saha D; Floyd JR; Sung P; Hromas R; Burns TC; Kittler R; Habib AA; Mukherjee B; Burma S
Cancer Res; 2021 Dec; 81(23):5935-5947. PubMed ID: 34580063
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial NIX Promotes Tumor Survival in the Hypoxic Niche of Glioblastoma.
Jung J; Zhang Y; Celiku O; Zhang W; Song H; Williams BJ; Giles AJ; Rich JN; Abounader R; Gilbert MR; Park DM
Cancer Res; 2019 Oct; 79(20):5218-5232. PubMed ID: 31488423
[TBL] [Abstract][Full Text] [Related]
7. Radiation therapy for glioma stem cells.
Rizzo AE; Yu JS
Adv Exp Med Biol; 2015; 853():85-110. PubMed ID: 25895709
[TBL] [Abstract][Full Text] [Related]
8. [Malignant gliomas--radiotherapy].
Schratter-Sehn A
Wien Med Wochenschr; 2006 Jun; 156(11-12):342-5. PubMed ID: 16944365
[TBL] [Abstract][Full Text] [Related]
9. Radiation Drives the Evolution of Orthotopic Xenografts Initiated from Glioblastoma Stem-like Cells.
McAbee JH; Rath BH; Valdez K; Young DL; Wu X; Shankavaram UT; Camphausen K; Tofilon PJ
Cancer Res; 2019 Dec; 79(23):6032-6043. PubMed ID: 31615806
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy-Induced Astrocyte Senescence Promotes an Immunosuppressive Microenvironment in Glioblastoma to Facilitate Tumor Regrowth.
Ji J; Ding K; Cheng B; Zhang X; Luo T; Huang B; Yu H; Chen Y; Xu X; Lin H; Zhou J; Wang T; Jin M; Liu A; Yan D; Liu F; Wang C; Chen J; Yan F; Wang L; Zhang J; Yan S; Wang J; Li X; Chen G
Adv Sci (Weinh); 2024 Apr; 11(15):e2304609. PubMed ID: 38342629
[TBL] [Abstract][Full Text] [Related]
11. The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells.
Sullivan KE; Rojas K; Cerione RA; Nakano I; Wilson KF
Oncotarget; 2017 Apr; 8(14):22325-22343. PubMed ID: 28423611
[TBL] [Abstract][Full Text] [Related]
12. Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy.
Yuan L; Siegel M; Choi K; Khosla C; Miller CR; Jackson EN; Piwnica-Worms D; Rich KM
Oncogene; 2007 Apr; 26(18):2563-73. PubMed ID: 17099729
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Derived Pericytes Driven by EGFR Mutations Govern the Vascular and Immune Microenvironment of Gliomas.
Segura-Collar B; Garranzo-Asensio M; Herranz B; Hernández-SanMiguel E; Cejalvo T; Casas BS; Matheu A; Pérez-Núñez Á; Sepúlveda-Sánchez JM; Hernández-Laín A; Palma V; Gargini R; Sánchez-Gómez P
Cancer Res; 2021 Apr; 81(8):2142-2156. PubMed ID: 33593822
[TBL] [Abstract][Full Text] [Related]
14. Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma.
Wild-Bode C; Weller M; Rimner A; Dichgans J; Wick W
Cancer Res; 2001 Mar; 61(6):2744-50. PubMed ID: 11289157
[TBL] [Abstract][Full Text] [Related]
15. Estimation of the effectiveness ratio (α/β) for resistant cancer cells in U87MG human glioblastoma.
Marmolejo-León P; Azorín-Vega EP; Jiménez-Mancilla N; Mendoza-Nava HJ; Mitsoura E; Pineda B; Torres-García E
Appl Radiat Isot; 2018 Nov; 141():156-161. PubMed ID: 29452949
[TBL] [Abstract][Full Text] [Related]
16. Chronic pathophysiological changes in the normal brain parenchyma caused by radiotherapy accelerate glioma progression.
Tsuji Y; Nonoguchi N; Okuzaki D; Wada Y; Motooka D; Hirota Y; Toho T; Yoshikawa N; Furuse M; Kawabata S; Miyatake SI; Nakamura H; Yamamoto R; Nakamura S; Kuroiwa T; Wanibuchi M
Sci Rep; 2021 Nov; 11(1):22110. PubMed ID: 34764346
[TBL] [Abstract][Full Text] [Related]
17. HSP47 Promotes Glioblastoma Stemlike Cell Survival by Modulating Tumor Microenvironment Extracellular Matrix through TGF-β Pathway.
Jiang X; Zhou T; Wang Z; Qi B; Xia H
ACS Chem Neurosci; 2017 Jan; 8(1):128-134. PubMed ID: 27696866
[TBL] [Abstract][Full Text] [Related]
18. Proinvasive extracellular matrix remodeling in tumor microenvironment in response to radiation.
Yoo KC; Suh Y; An Y; Lee HJ; Jeong YJ; Uddin N; Cui YH; Roh TH; Shim JK; Chang JH; Park JB; Kim MJ; Kim IG; Kang SG; Lee SJ
Oncogene; 2018 Jun; 37(24):3317-3328. PubMed ID: 29559744
[TBL] [Abstract][Full Text] [Related]
19. Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model.
Okolie O; Bago JR; Schmid RS; Irvin DM; Bash RE; Miller CR; Hingtgen SD
Neuro Oncol; 2016 Dec; 18(12):1622-1633. PubMed ID: 27298311
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane synthase regulates the migratory phenotype of human glioma cells.
Giese A; Hagel C; Kim EL; Zapf S; Djawaheri J; Berens ME; Westphal M
Neuro Oncol; 1999 Jan; 1(1):3-13. PubMed ID: 11550298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
